Todd Warren Rockway

This inventor holds 39 USPTO granted patents and 6 published patent applications, plus 9 CIPO patents and 15 EPO patents, primarily in Antiviral Compounds. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Abbott Products Gmbh. Active years: 1997-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Todd Warren Rockway. Retrieved from https://idiyas.com/inventor/todd-warren-rockway

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 39 (Patent Applications = 6)

% Patents Active = 82.1

CIPO Patents = 9 (Patent Applications = 11)

EPO Patents = 15 (Patent Applications = 21)

Average Co-Inventor Count = 15.2

ph-index = 9

Forward Citations = 250(Granted Patents)

Location History:

Gurnee, IL (US) (2014 - 2017)
Grayslake, IL (US) (1997 - 2018)

Company Filing History:

Abbott Laboratories Corporation

where one patent can have more than one assignee

Years Active: 1997-2018

Loading Chart...

Areas of Expertise:

Antiviral Compounds

Hepatitis C Inhibitors

Anti-Infective Agents

Farnesyltransferase Inhibitors

Urokinase Inhibitors

Squalene Synthase Inhibitors

Naphthamidine Urokinase Inhibitors

HCV Protease Inhibitors

Protein Farnesyltransferase Inhibitors

Inhibitors of Squalene Synthase

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10039754 - Anti-viral compounds (2018-08-07),

2. 10028937 - Anti-viral compounds (2018-07-24),

3. 9637478 - Antiviral compounds and uses thereof (2017-05-02),

4. 9586978 - Anti-viral compounds (2017-03-07),

5. 9567355 - Hepatitis C inhibitors and uses thereof (2017-02-14),

6. 9453007 - Hepatitis C inhibitors and uses thereof (2016-09-27),

7. 9353091 - Antiviral compounds and uses thereof (2016-05-31),

8. 9173887 - Hepatitis C inhibitors and uses thereof (2015-11-03),

9. 9139536 - Anti-infective agents and uses thereof (2015-09-22),

10. 9095590 - Anti-infective agents and uses thereof (2015-08-04),

11. 9006387 - Anti-viral compounds (2015-04-14),

12. 8986740 - Anti-infective agents and uses thereof (2015-03-24),

13. 8937150 - Anti-viral compounds (2015-01-20),

14. 8921514 - Anti-viral compounds (2014-12-30),

15. 8748443 - Antiviral compounds and uses thereof (2014-06-10),

Title: The Innovative Journey of Todd Warren Rockway

Introduction: Todd Warren Rockway, a visionary inventor based in Grayslake, IL (US), epitomizes the essence of innovation and its profound influence on shaping the future. His remarkable journey of advancements in technology continues to ignite inspiration among inventors worldwide.

Latest Patents: Todd Warren Rockway holds an impressive portfolio of 39 patents, with his latest groundbreaking inventions focusing on anti-viral compounds effective in inhibiting the replication of the Hepatitis C virus (HCV). These compounds, along with their related processes, compositions, and treatment methods, showcase his dedication to combating infectious diseases.

Career Highlights: Rockway's innovative spirit has been nurtured through his tenure at renowned companies such as AbbVie Inc. and Abbott Laboratories Corporation, where he honed his skills and spearheaded cutting-edge research initiatives. His contributions have significantly impacted the fields of pharmaceuticals and healthcare.

Collaborations: Throughout his career, Todd Warren Rockway has collaborated with esteemed professionals in the industry, including Dachun Liu and David A. Betebenner. These collaborations have facilitated the exchange of ideas, expertise, and a collective drive towards achieving excellence in innovation.

Conclusion: Todd Warren Rockway's unwavering commitment to pushing the boundaries of scientific discovery stands as a testament to the transformative power of innovation. His revolutionary inventions not only reflect his ingenuity but also inspire a new generation of inventors to strive for excellence and make a lasting impact on society.

Profile summary based on public USPTO records.